Irbesartan
- Product NDC
- 72162-2355
- 11-digit product format
- 721622355
- Labeler code
- 72162
- Product ID
- 72162-2355_ab7543dc-4fcb-459d-93a2-619ea8389282
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irbesartan
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA203071
- Marketing category
- ANDA
- Marketing start
- 2016-06-13
- Substance
- IRBESARTAN
- Active strength
- 150 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203071-001 | IRBESARTAN | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | |
| A203071-002 | IRBESARTAN | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | |
| A203071-003 | IRBESARTAN | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203071-001 | AB |
| A203071-002 | AB |
| A203071-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203071-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-09-27 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203071-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-09-27 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A203071-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-09-27 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203071-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203071-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203071-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203071-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203071-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203071-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A203071-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203071-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203071-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203071-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203071-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203071-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203071-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203071-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203071-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203071-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203071-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203071-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203071-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203071-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203071-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203071-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203071-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203071-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203071-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203071-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203071-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A203071-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A203071-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A203071-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203071-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203071-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203071-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203071-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203071-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203071-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203071-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203071-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203071-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A203071-001 | AB | 1 | 8072bd15b7f6… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Irbesartan
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| IRBESARTAN | 150 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| J0E2756Z7N | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 200095 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| ecc490ea-a68e-4261-8be2-5020ac5ab803 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 34942a29-de4f-d63c-7755-ba18fe1411a0 | Product name | 6 | 20180619 |
| a7349398-661d-d9fc-46df-7e128bbd61d9 | Product name | 5 | 20171113 |
| e0eeb018-194e-4b70-a57d-bac47a97b8ea | Product name | 1 | 20160825 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2355-3 | Irbesartan | 30 in 1 BOTTLE | TABLET | 30 | 101 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2355-3 | EA - Each | 72162-2355 | 697e5e85-a1db-45e8-b0a4-3516d8f684e9 | 1 | 2024-08-12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-2355 | IRBESARTAN TABLET [BRYANT RANCH PREPACK] | 101 | Current NDC, 1 package rows | 20240709_ecc490ea-a68e-4261-8be2-5020ac5ab803.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Irbesartan | IRBESARTAN | REMEDYREPACK INC. | 029a90b6-0722-49be-8400-3ec29526aafd | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | 203071 ANDA203071 |
| Irbesartan | IRBESARTAN | REMEDYREPACK INC. | 9adacfa2-2814-4deb-9e34-c3b3c8dcd41a | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 203071 ANDA203071 |
| Irbesartan | IRBESARTAN | Bryant Ranch Prepack | 14d85774-2d74-4300-b4bb-c2836db4d5bd | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 203071 ANDA203071 |
| Irbesartan | IRBESARTAN | Solco Healthcare U.S., LLC | 6916c617-92d2-44f5-b968-6267517a2ce6 | 2025-09-30 | Boxed warning, Warnings, Adverse reactions | 203071 ANDA203071 |
| Irbesartan | IRBESARTAN | A-S Medication Solutions | 70a25c6d-23ce-488c-9ef8-62b3b99e5052 | 2025-08-08 | Boxed warning, Warnings, Adverse reactions | 203071 ANDA203071 |
| Irbesartan | IRBESARTAN | A-S Medication Solutions | 6babdb48-8384-49ce-a759-d380d79a4010 | 2025-08-08 | Boxed warning, Warnings, Adverse reactions | 203071 ANDA203071 |
| Irbesartan | IRBESARTAN | Bryant Ranch Prepack | ecc490ea-a68e-4261-8be2-5020ac5ab803 | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | 203071 ANDA203071 72162-2355 |
| Irbesartan | IRBESARTAN | Bryant Ranch Prepack | efcd5f2e-1837-44ae-bc91-410c4d8b27c7 | 2023-11-27 | Boxed warning, Warnings, Adverse reactions | 203071 ANDA203071 |
| Irbesartan | IRBESARTAN | Bryant Ranch Prepack | 1ab1ff46-d0b1-4762-9ebf-3e07dde8b048 | 2023-11-27 | Boxed warning, Warnings, Adverse reactions | 203071 ANDA203071 |
| Irbesartan | IRBESARTAN | Proficient Rx LP | b587d89b-8ff9-4180-b31a-bbff5d365a1d | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 203071 ANDA203071 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 200095 | irbesartan 150 MG Oral Tablet | PSN | ecc490ea-a68e-4261-8be2-5020ac5ab803 | 101 |
| 200095 | irbesartan 150 MG Oral Tablet | SCD | ecc490ea-a68e-4261-8be2-5020ac5ab803 | 101 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72162-2355-3 | 72162235503 | 30 TABLET in 1 BOTTLE (72162-2355-3) | 30 tablet | 2024-06-28 | No | No | Current |